Invertebrate animal models as tools to study fungal pathogenesis and treatment

Journal of Invasive Fungal Infections

Volumn 4, Issue 4, 2010, Pages 127-132

  Muhammed, Maged ^a   Coleman, Jeffrey J ^a   Kourkoumpetis, Themistoklis K ^a   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ASPERGILLUS; CAENORHABDITIS ELEGANS; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DROSOPHILA MELANOGASTER; DRUG EFFICACY; FUNGAL VIRULENCE; FUNGUS PATHOGENESIS; GALLERIA MELLONELLA; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; INVERTEBRATE; NONHUMAN; PATHOGENESIS; REVIEW;

EID: 83455212083     PISSN: 17533783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Bhabhra R, Miley MD, Mylonakis E et al. Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun 2004;72:4731-40. (Pubitemid 38989334)
2. Laws TR, Smith SA, Smith MP et al. The nematode Panagrellus redivivus is susceptible to killing by human pathogens at 37 degrees C. FEMS Microbiol Lett 2005;250:77-83. (Pubitemid 41149007)
3. Sekiya M, Ueda K, Okazaki K et al. A cyclopentanediol analogue selectively suppresses the conserved innate immunity pathways, Drosophila IMD and TNF-alpha pathways. Biochem Pharmacol 2008;75:2165-74.
4. Means TK, Mylonakis E, Tampakakis E et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009;206:637-53.
5. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000;27:163-9. (Pubitemid 30047095)
6. Mylonakis E, Moreno R, El Khoury JB et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005;73:3842-50. (Pubitemid 40923121)
7. Brennan M, Thomas DY, Whiteway M et al. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 2002;34:153-7.
8. Alarco AM, Marcil A, Chen J et al. Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens. J Immunol 2004;172:5622-8. (Pubitemid 38542065)
9. Chamilos G, Nobile CJ, Bruno VM et al. Candida albicans Cas5, a regulator of cell wall integrity, is required for virulence in murine and toll mutant fly models. J Infect Dis 2009;200:152-7.
10. Pukkila-Worley R, Peleg AY, Tampakakis E et al. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009;8:1750-8.
11. Fuchs BB, Eby J, Nobile CJ et al. Role of filamentation in Galleria mellonella killing by Candida albicans. Microbes Infect 2010;12:488-96.
12. Askew C, Sellam A, Epp E et al. Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog 2009;5:e1000612.
13. Mylonakis E, Ausubel FM, Perfect JR et al. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A 2002;99:15675-80. (Pubitemid 35403990)
14. Apidianakis Y, Rahme LG, Heitman J et al. Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell 2004;3:413-9. (Pubitemid 38497980)
15. Tang RJ, Breger J, Idnurm A et al. Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun 2005;73:8219-25. (Pubitemid 41740311)
16. Petzold EW, Himmelreich U, Mylonakis E et al. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect Immun 2006;74:5877-87. (Pubitemid 44484575)
17. Mylonakis E, Idnurm A, Moreno R et al. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 2004;54:407-19. (Pubitemid 39388285)
18. Jong A, Wu CH, Chen HM et al. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell 2007;6:1486-96. (Pubitemid 47257717)
19. Chayakulkeeree M, Sorrell TC, Siafakas AR et al. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol Microbiol 2008;69:809-26. (Pubitemid 352033304)
20. Kozubowski L, Heitman J. Septins enforce morphogenetic events during sexual reproduction and contribute to virulence of Cryptococcus neoformans. Mol Microbiol 2009;75:658-75.
21. Spikes S, Xu R, Nguyen CK et al. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis 2008;197:479-86. (Pubitemid 351263432)
22. Reeves EP, Reiber K, Neville C et al. A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in Aspergillus fumigatus. FEBS J 2006;273:3038-53.
23. Voelz K, May RC. Cryptococcal interactions with the host immune system. Eukaryot Cell 2010;9:835-46.
24. D'Souza CA, Alspaugh JA, Yue C et al. Cyclic AMP-dependent protein kinasecontrols virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 2001;21:3179-91. (Pubitemid 32298384)
25. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 2009;56:211-24.
26. Reeves EP, Messina CG, Doyle S et al. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia 2004;158:73-9. (Pubitemid 39187856)
27. Scully LR, Bidochka MJ. The host acts as a genetic bottleneck during serial infections: an insect-fungal model system. Curr Genet 2006;50:335-45. (Pubitemid 44613094)
28. Scully LR, Bidochka MJ. An alternative insect pathogenic strategy in an Aspergillus flavus auxotroph. Mycol Res 2009;113:230-9.
29. Chamilos G, Lionakis MS, Lewis RE et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 2006;193:1014-22.
30. Lionakis MS, Lewis RE, May GS et al. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 2005;191:1188-95. (Pubitemid 40404379)
31. Rowan R, Moran C, McCann M et al. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. Biometals 2009;22:461-7.
32. Breger J, Fuchs BB, Aperis G et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 2007;3:e18.
33. Tampakakis E, Okoli I, Mylonakis E. A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds. Nat Protoc 2008;3:1925-31.
34. Okoli I, Coleman JJ, Tempakakis E et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 2009;4:e7025.
35. Coleman JJ, Okoli I, Tegos GP et al. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 2010;5:321-32.